Oxcia AB
PrivateLast Round
Private Equity
Jun 27, 2025
Est. Valuation
$15.81M
Total Funding Raised
$5.73M
Company Overview
Oxcia AB operates in Healthcare & Life Sciences and is based in Stockholm. Its latest recorded funding round was a Private Equity round in June 2025.
Oxcia AB is a biotechnology company that develops innovative treatments for cancer and inflammatory diseases by targeting oxidative DNA damage and DNA Damage Response pathways.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Oxcia AB Comparables
Compare Oxcia AB with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Artios Pharma | 80% | |
| Onco-Innovations | 71% | |
| Repare Therapeutics | 66% |
For institutional investors. Book with your work email.
Oxcia AB Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Equity | Jun 27, 2025 | ||||
| VC Round | Oct 10, 2023 | ||||
| Grant | Apr 1, 2023 | ||||
| Grant | Feb 24, 2023 | ||||
| Private Placement | Feb 1, 2022 | ||||
Private Placement | Mar 26, 2021 |
For institutional investors. Book with your work email.
Oxcia AB Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| Vinnova | Grant |
| Swelife | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 16, 2026
Monthly visitors grew 267% MoM, reaching 2.6K.
- Jun 27, 2025
Raised $2.76M from Thomas Helleday.
For institutional investors. Book with your work email.
Oxcia AB Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Oxcia AB's valuation, stock price, and market status.
Is Oxcia AB a public or private company?
Oxcia AB is a private company.
What is the current stock price of Oxcia AB?
Oxcia AB is a private company, so its shares have no public market price. Caplight tracks Oxcia AB's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Oxcia AB worth (valuation)?
Oxcia AB's valuation is estimated at $15.8M based on funding round data.
Can I buy Oxcia AB stock?
Oxcia AB shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Oxcia AB's last funding round?
Oxcia AB's most recent funding round was Private Equity on June 27, 2025.
Who are the main investors in Oxcia AB?
Key investors in Oxcia AB include European Innovation Council Fund, Vinnova, Swelife.
Will Oxcia AB IPO soon?
No public IPO plans have been announced for Oxcia AB.
How can I track Oxcia AB secondary market activity?
Caplight tracks bids, offers, and trades in Oxcia AB's shares on secondary markets.